Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medicover AB's Enterprise Value is €4,379 Mil.
Medicover AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was €166 Mil. Therefore, Medicover AB's EV-to-EBIT ratio for today is 26.33.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Medicover AB's Enterprise Value is €4,379 Mil.
Medicover AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €386 Mil. Therefore, Medicover AB's EV-to-EBITDA ratio for today is 11.36.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Medicover AB's Enterprise Value is €4,379 Mil.
Medicover AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was €2,424 Mil. Therefore, Medicover AB's EV-to-Revenue ratio for today is 1.81.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Medicover AB's Enterprise Value is €4,379 Mil.
Medicover AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €173 Mil. Therefore, Medicover AB's EV-to-FCF ratio for today is 25.33.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Medicover AB (FRA:5M0B) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Medicover AB's current Enterprise Value is €4,379 Mil.
Medicover AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €166 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Medicover AB's current Enterprise Value is €4,379 Mil.
Medicover AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €386 Mil.
Medicover AB's current Enterprise Value is €4,379 Mil.
Medicover AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2,424 Mil.
Medicover AB's current Enterprise Value is €4,379 Mil.
Medicover AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €329 Mil.
Medicover AB's current Enterprise Value is €4,379 Mil.
Medicover AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €173 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicover AB Enterprise Value Related Terms
Medicover AB Enterprise Value Historical Data
* Premium members only.
The historical data trend for Medicover AB's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:5M0B vs HCA, THC, DVA: Enterprise Value Comparison
For the Medical Care Facilities subindustry, Medicover AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicover AB Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Medicover AB's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Medicover AB's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicover AB (FRA:5M0B) has a Enterprise Value of €4,379 Mil as of Jul. 18, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Medicover AB and its competitors.
Is Medicover AB's Enterprise Value too high?
Medicover AB's current Enterprise Value is €4,379 Mil. Overall, Medicover AB has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Enterprise Value compare to HCA and THC?
Medicover AB's Enterprise Value of €4,379 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Medicover AB and its competitors. Medicover AB's current Enterprise Value is €4,379 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (FRA:5M0B) is currently considered Fairly Valued. The stock's GF Value™ is €20.76, compared to a current price of €19.72 — trading 5% below its estimated fair value. The current Enterprise Value is €4,379 Mil. Medicover AB's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Medicover AB (FRA:5M0B), the current Enterprise Value is €4,379 Mil as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicover AB (FRA:5M0B) Overvalued in 2026?
Based on GuruFocus' analysis, Medicover AB stock appears to be undervalued.
The current stock price of €19.72 is trading 5% below its estimated GF Value™ of €20.76.
GuruFocus considers Medicover AB to be Fairly Valued.
Key valuation signals for FRA:5M0B:
Enterprise Value: €4,379 Mil
GF Value™: €20.76 vs. price of €19.72 (5% below fair value)
No single metric tells the full story. See the FRA:5M0B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
89GF Score
Get the complete analysis for FRA:5M0B
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5M0B has been successfully added to your 
